Our results indicated baicalein and baicalin can induce selective modulation of specific MAPK p38 and ERK1/2 signaling pathways in human colon cancer cells that might control the molecular processes of tumor cell cycle arrest, apoptosis and senescence. This evidence concerns the gene MAPK3 and malignant colon neoplasm.